New hope for patients with sarcopenic obesity unable to join clinical trials
Disease control
TEMPORARILY_NOT_AVAILABLE
This program provides early access to an experimental treatment called IMM01-STEM for people with sarcopenic obesity—a condition where both muscle loss and excess body fat occur. It is designed for patients who cannot participate in other clinical trials due to location, eligibil…
Sponsor: Immunis, Inc. • Aim: Disease control
Last updated May 02, 2026 18:43 UTC